Help
RSS
API
Feed
Maltego
Contact
Domain > www.hemlibra.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-04-14
52.52.131.56
(
ClassC
)
2019-09-18
52.9.196.166
(
ClassC
)
2020-03-10
52.52.28.20
(
ClassC
)
2020-04-20
52.52.188.226
(
ClassC
)
2021-03-10
52.52.89.208
(
ClassC
)
2025-05-17
104.18.15.66
(
ClassC
)
2026-02-17
104.18.14.66
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Thu, 24 Oct 2024 04:48:33 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Thu, 24 Oct 2024 05:48:33 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Thu, 24 Oct 2024 04:48:33 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cfruid !DOCTYPE HTML>html langen> head> meta charsetUTF-8/> title>HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment/title> meta namedescription contentLearn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING./> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.hemlibra.com//> meta propertyog:site_name contenthemlibra/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentHEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment/> meta propertyog:description contentLearn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING./> meta propertyog:url contenthttps://www.hemlibra.com//> meta propertyog:image contenthttps://www.hemlibra.com/content/dam/gene/hemlibra/images/041719_Hemlibra_US_External_Logo_150_RGB_R.genecoreimg.1200.svg/> meta propertyog:image:type contentimage/svg+xml/> meta propertyog:image:width content863/> meta propertyog:image:height content369/> meta propertyog:image:alt contentHEMLIBRA® (emicizumab-kxwh): A treatment approved for Hemophilia A patients with or without FVIII inhibitors. See Safety Information including BOXED WARNING./> meta nametwitter:card contentsummary_large_image/> meta namepub_date content2024-02-20T12:02:10-0800/> link relicon typeimage/x-icon href/content/dam/gene/hemlibra-hcp/images/favicon.png/> link relshortcut icon typeimage/x-icon href/content/dam/gene/hemlibra-hcp/images/favicon.png/> link hrefhttps://fonts.googleapis.com/css2?familyOpen+Sans:ital,wght@0,400;0,700;1,400;1,700&displayswap relstylesheet/> script typetext/plain classoptanon-category-C0002> window.NREUM||(NREUM{}),__nr_requirefuncti
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]